Single-Cell Transcriptomics of the Peritoneal Microenvironment of Colorectal PC
NCT05676372 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-12-28
Summary
Single cell transcriptomics of CRC PC samples
Conditions
- Peritoneal Metastases
Interventions
- PROCEDURE
-
CRC+HIPEC
Sample prelevation of cytoreductive surgery
Sponsors & Collaborators
-
Flemish institute of biotechnology (VIB)
collaborator OTHER -
University Hospital, Ghent
lead OTHER
Principal Investigators
-
Wim Ceelen, MD, PhD · UZ Ghent
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-16
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC
NCT06195670 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
NCT00559676 ·Status: COMPLETED ·Phase: PHASE4
-
Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal Cancer
NCT05172635 ·Status: COMPLETED
-
A Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment(DOFEMCRC)
NCT05025631 ·Status: COMPLETED ·Phase: PHASE2
-
FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage
NCT05279677 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
NCT01679327 ·Status: UNKNOWN ·Phase: PHASE2
-
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
NCT00250029 ·Status: COMPLETED ·Phase: NA
-
Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer
NCT03613194 ·Status: UNKNOWN ·Phase: NA
-
Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP)
NCT02511756 ·Status: TERMINATED ·Phase: NA
-
Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers
NCT04103567 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma
NCT04758507 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials
NCT03350412 ·Status: UNKNOWN
-
Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy
NCT01677884 ·Status: COMPLETED ·Phase: PHASE2
-
Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers
NCT06435689 ·Status: NOT_YET_RECRUITING
-
Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer
NCT02117466 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer
NCT01319877 ·Status: COMPLETED
-
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
NCT05639413 ·Status: RECRUITING ·Phase: NA
-
Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' Treatment
NCT03028155 ·Status: UNKNOWN ·Phase: PHASE3
-
AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond
NCT06678919 ·Status: RECRUITING
-
FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis
NCT06801665 ·Status: RECRUITING ·Phase: PHASE2
-
A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
NCT02026583 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With Chemotherapy Combined With Bevacizumab
NCT02673710 ·Status: COMPLETED
-
Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology
NCT03797053 ·Status: UNKNOWN
-
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung
NCT00557102 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
NCT00563316 ·Status: COMPLETED ·Phase: PHASE1